88326351
Mar 5, 2019
Pharmaceutical preparations for the treatment of pain, disease, illness, and injury; pharmaceutical preparations for the treatment of neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, and metabolic disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for therapeutic purposes in the treatment of pain, disease, illness, and injury; pharmaceutical preparations for the treatment of mental illness; dietary supplements; all of the foregoing containing CBD solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Pharmaceuticals